Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay

Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay

Sponsors and Collaborators
Lawson Health Research Institute
Astellas Pharma Canada, Inc.

Contact
Dr. Patrick Luke, MD
519-685-8500 ext 33180

Principal Investigator
Patrick Luke, MD, FRCSC, Lawson Health Research Institute

ClinicalTrials.gov Identifier
NCT01859832

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters